Furthermore, CD45neg tumor/stromal cells in B16 tumors treated with ADU-S100 + anti-ISG15 (vs. ADU-S100 alone) expressed higher levels of MHC II, with a trend for increased expression of PD-L1 (p = 0.1042; Supplementary Figure 6F). The gene discussed is ISG15; the disease is neoplasm.